PMG Research announces formation of VaxCorps with two industry-leading vaccine site networks

Share Article

Benchmark Research, Miami Research Associates, and PMG Research form VaxCorps to bring transformative solutions to the industry, driven by shared best practices for standardization and reproducibility across large-scale vaccine trials.

PMG Research logo

PMG Research

PMG Research is proud to be a part of this unique partnership with Benchmark Research and Miami Research Associates,

PMG Research, Benchmark Research, and Miami Research Associates are pleased to announce the formation of VaxCorps, a network of highly experienced, geographically diverse clinical research centers specializing in the conduct of vaccine trials in healthy adult, elderly, and pediatric populations. VaxCorps clinical sites have successfully conducted over 500 phase I-III vaccine clinical trials, with extensive experience in seasonal and pandemic influenza as well as a vast array of other infectious and biodefense vaccine indications. As industry leaders, VaxCorps is committed to the highest standard of research excellence with subject safety, data integrity, rapid study start-up and enrollment, and outstanding subject retention as top priorities.

Though the VaxCorps name is new, the players are all well-known and highly respected in the industry. As a testament to this, Benchmark Research, Miami Research, and PMG Research were all recently selected by their clients and peers as finalists for Best Clinical Trial Site or Network at the 2015 World Vaccine Congress’ Vaccine Industry Excellence Awards. Most noteworthy of all, VaxCorps members comprise 50% of the pool of finalists. Come to the meeting to see which site will take home the award and be sure to visit VaxCorps at booth #40 to learn more about this exciting new initiative.

“PMG Research is proud to be a part of this unique partnership with Benchmark Research and Miami Research Associates,” explains Amanda Wright, Senior Director of Client Services at PMG Research. “As like-minded organizations, our goals include achieving rapid study start up, collecting evaluable data, and reducing cost, all ultimately aimed at improving patient outcomes and contributing to the advancement of healthcare treatment. We are confident VaxCorps will bring new solutions to the industry for standardized execution of vaccine trials.”

About PMG Research
PMG Research, Inc. is an integrated network of clinical research facilities with hub sites located in Cary, Charlotte, Hickory, Raleigh, Rocky Mount, Salisbury, Wilmington, and Winston-Salem, NC; Charleston, SC; and Bristol and Knoxville, TN. PMG has conducted 7,200 research studies for hundreds of pharmaceutical sponsors and CROs since 1979. We have extensive experience conducting all phases of trials across a comprehensive list of conditions. Our mission is to bring clinical research to as many lives as possible while delivering unparalleled service and exceptional value to our clinical trial partners and stakeholders. To learn more, visit http://www.PMG-Research.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Kristin Kinlaw
Follow us on
Visit website